BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14581357)

  • 1. Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity.
    Hisai H; Kato J; Kobune M; Murakami T; Miyanishi K; Takahashi M; Yoshizaki N; Takimoto R; Terui T; Niitsu Y
    Clin Cancer Res; 2003 Oct; 9(13):4852-9. PubMed ID: 14581357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?
    Moon WS; Rhyu KH; Kang MJ; Lee DG; Yu HC; Yeum JH; Koh GY; Tarnawski AS
    Mod Pathol; 2003 Jun; 16(6):552-7. PubMed ID: 12808060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of ESM-1 in hepatocellular carcinoma is associated with angiogenesis and tumor invasion].
    Xiang X; Zhao WB; Wang X
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):661-4. PubMed ID: 19785952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor.
    Mise M; Arii S; Higashituji H; Furutani M; Niwano M; Harada T; Ishigami S; Toda Y; Nakayama H; Fukumoto M; Fujita J; Imamura M
    Hepatology; 1996 Mar; 23(3):455-64. PubMed ID: 8617424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
    Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
    Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
    Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
    Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
    Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.
    Kim KW; Bae SK; Lee OH; Bae MH; Lee MJ; Park BC
    Cancer Res; 1998 Jan; 58(2):348-51. PubMed ID: 9443416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma.
    Poon RT; Chung KK; Cheung ST; Lau CP; Tong SW; Leung KL; Yu WC; Tuszynski GP; Fan ST
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4150-7. PubMed ID: 15217952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients.
    Jin-no K; Tanimizu M; Hyodo I; Nishikawa Y; Hosokawa Y; Endo H; Doi T; Mandai K; Ishitsuka H
    Cancer; 1998 Apr; 82(7):1260-7. PubMed ID: 9529017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
    Batmunkh E; Tátrai P; Szabó E; Lódi C; Holczbauer A; Páska C; Kupcsulik P; Kiss A; Schaff Z; Kovalszky I
    Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma.
    Mitsuhashi N; Shimizu H; Ohtsuka M; Wakabayashi Y; Ito H; Kimura F; Yoshidome H; Kato A; Nukui Y; Miyazaki M
    Hepatology; 2003 May; 37(5):1105-13. PubMed ID: 12717391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma.
    Matsumoto K; Ishikawa H; Nishimura D; Hamasaki K; Nakao K; Eguchi K
    Hepatology; 2004 Jul; 40(1):252-9. PubMed ID: 15239109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
    Dhar DK; Ono T; Yamanoi A; Soda Y; Yamaguchi E; Rahman MA; Kohno H; Nagasue N
    Cancer; 2002 Nov; 95(10):2188-95. PubMed ID: 12412173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
    Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
    Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.